Axon Enterprise, Inc $AXON Position Raised by Cabot Wealth Management Inc.

Posted by Brian Himes on Nov 12th, 2026

Cabot Wealth Management Inc. boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 11,781.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 223,139 shares of the biotechnology company’s stock after purchasing an additional 221,261 shares during the quarter. Axon Enterprise comprises 8.7% of Cabot Wealth Management Inc.’s portfolio, making the stock its largest position. Cabot Wealth Management Inc. owned approximately 0.27% of Axon Enterprise worth $94,281,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. MassMutual Private Wealth & Trust FSB lifted its stake in Axon Enterprise by 122,993.6% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 461,601 shares of the biotechnology company’s stock valued at $195,036,000 after acquiring an additional 461,226 shares during the period. B. Metzler seel. Sohn & Co. AG purchased a new stake in shares of Axon Enterprise during the 2nd quarter valued at about $3,854,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of Axon Enterprise in the first quarter worth approximately $15,067,000. Brown Lisle Cummings Inc. grew its stake in shares of Axon Enterprise by 97,231.4% in the second quarter. Brown Lisle Cummings Inc. now owns 34,066 shares of the biotechnology company’s stock worth $19,098,000 after acquiring an additional 34,031 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. grew its stake in shares of Axon Enterprise by 40.7% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock worth $6,406,000 after acquiring an additional 4,360 shares during the period. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey Kunins sold 9,605 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the sale, the insider directly owned 97,761 shares of the company’s stock, valued at $61,266,818.70. This represents a 8.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the transaction, the insider owned 56,264 shares of the company’s stock, valued at $27,032,038.80. This represents a 1.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 37,397 shares of company stock valued at $21,234,034 over the last 90 days. Insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Up 4.3%

AXON opened at $315.42 on Thursday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.60 and a current ratio of 3.00. Axon Enterprise, Inc has a fifty-two week low of $291.45 and a fifty-two week high of $665.07. The firm’s fifty day moving average is $426.24 and its 200 day moving average is $470.65. The stock has a market cap of $25.68 billion, a price-to-earnings ratio of 101.10, a price-to-earnings-growth ratio of 5.75 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The business had revenue of $908.55 million for the quarter, compared to the consensus estimate of $934.33 million. During the same period last year, the business posted $1.17 EPS. The firm’s revenue for the quarter was up 27.8% compared to the same quarter last year. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Axon Enterprise News Roundup

Here’s some of the latest news about AXON:

Positive Sentiment: Northland maintained a $540 price target despite Axon’s steep decline from its August high, signaling that at least one analyst sees meaningful potential upside. A price target is an estimate, not a guarantee. Axon Is Down 52% From Its August High. Northland Still Sees $540
Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
Neutral Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will distribute its products to U.S. public-safety customers. The deal could broaden Axon’s offering, but its sizeable cost makes the investment a factor for investors to weigh. Axon invests $1.2B into Skydio and becomes its U.S. public safety distributor

Analyst Ratings Changes

A number of research analysts recently weighed in on AXON shares. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. UBS Group boosted their target price on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Argus increased their price target on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. Morgan Stanley increased their price target on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Thirteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $612.18.

Get Our Latest Analysis on AXON

About Axon Enterprise

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.